Lack of Plasminogen Activator Inhibitor-1 Promotes Growth and Abnormal Matrix Remodeling of Advanced Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
REGULATION OF IMMUNE RESPONSES BY TGF-β
1998 • 1,908 citations
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
1987 • 1,516 citations
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
1997 • 958 citations
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
1999 • 790 citations
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
1997 • 664 citations
Induction of tenascin in healing wounds.
1988 • 563 citations
Transforming growth factor-beta: a general review.
1996 • 400 citations
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.
1993 • 399 citations
Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation
1980 • 372 citations
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
1994 • 363 citations
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.
1993 • 344 citations
Association of Fibrinolytic Parameters With Early Atherosclerosis
1995 • 287 citations
Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
1993 • 264 citations
TGF-β1 Prevents Hypertrophy of Epiphyseal Chondrocytes: Regulation of Gene Expression for Cartilage Matrix Proteins and Metalloproteases
1993 • 240 citations
The influence of tissue section thickness on the study of collagen by the Picrosirius-polarization method
1982 • 235 citations
Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes.
1993 • 211 citations
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery
2000 • 179 citations
Proteolytic control of growth factor availability
1999 • 157 citations
Regulation of cell adhesion by PAI‐1
1999 • 154 citations
Viewpoint: Are Studies in Genetically Altered Mice Out of Control?
2000 • 126 citations
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
1997 • 125 citations
Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages.
1994 • 124 citations
Vascular development and disorders: Molecular analysis and pathogenic insights
1998 • 110 citations
Plasminogen Activator Inhibitor Type 1 Enhances Neointima Formation After Oxidative Vascular Injury in Atherosclerosis-Prone Mice
2001 • 97 citations
Atherosclerosis Progression in LDL Receptor–Deficient and Apolipoprotein E–Deficient Mice Is Independent of Genetic Alterations in Plasminogen Activator Inhibitor-1
2000 • 86 citations
Delayed appearance of decorin in healing burn scars
2000 • 82 citations
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
1998 • 81 citations
Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1
2001 • 74 citations
Proteoglycans in arterial smooth muscle cell cultures: an ultrastructural histochemical analysis.
1984 • 55 citations
Fibrinolytic Proteins and Progression of Coronary Artery Disease in Relation to Gemfibrozil Therapy
2000 • 15 citations